Wnt/β-catenin pathway mediates (−)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

Wnt/β-catenin pathway mediates (−)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells

详细信息查看全文

作者：Jianyun Zhu^a ; Ye Jiang^a ; Xue Yang^a ; Shijia Wang^a ; Chunfeng Xie^a ; ^b ; Xiaoting Li^a ; ^b ; Yuan Li^a ; Yue Chen^a ; Xiaoqian Wang^a ; Yu Meng^a ; Mingming Zhu^a ; Rui Wu^a ; Cong Huang^a ; Xiao Ma^a ; Shanshan Geng^a ; ^b ; Jieshu Wu^a ; ^b ; Caiyun Zhong^a ; ^b ; ^{cyzhong@njmu.edu.cn}
关键词：EGCG ; Lung cancer stem cells ; Wnt/β-catenin pathway ; Inhibition
刊名：Biochemical and Biophysical Research Communications
出版年：2017
出版时间：1 January 2017
年：2017
卷：482
期：1
页码：15-21
全文大小：1473 K
卷排序：482

文摘

EGCG inhibited lung CSCs activity. EGCG inhibited lung CSCs activity via Wnt/β-catenin pathway suppression. EGCG may prove to be a potential therapeutic agent for lung cancer.